GILD - Company ID 0000882095
GILEAD SCIENCES, INC. (GILD) reported revenue of $29.44B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $29.44B | +2.4% |
| FY 2024 | $28.75B | +6.0% |
| FY 2023 | $27.12B | -0.6% |
| FY 2022 | $27.28B | -0.1% |
| FY 2021 | $27.30B | +10.6% |
| FY 2020 | $24.69B | +10.0% |
| FY 2019 | $22.45B | +1.5% |
| FY 2018 | $22.13B | -15.2% |
| FY 2017 |
GILEAD SCIENCES, INC. (GILD) reported revenue of $29.44B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, GILEAD SCIENCES, INC.'s revenue grew from $8.39B to $29.44B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $26.11B |
| -14.1% |
| FY 2016 | $30.39B | -6.9% |
| FY 2015 | $32.64B | +31.1% |
| FY 2014 | $24.89B | +122.2% |
| FY 2013 | $11.20B | +15.5% |
| FY 2012 | $9.70B | +15.7% |
| FY 2011 | $8.39B | - |